Specificity within the EGF family/ErbB receptor family signaling network

BioEssays

Volumn 20, Issue 1, 1998, Pages 41-48

  Riese II, David J ^a,b   Stern, David F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ONCOPROTEIN;

ANIMAL; BINDING SITE; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; EPIDERMAL GROWTH FACTOR; HUMANS; ONCOGENE PROTEINS V-ERBB; SIGNAL TRANSDUCTION;

EID: 0031936410     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V     Document Type: Review

References (83)

1. Hynes, N.E., and Stern, D.F. (1994). The biology of erbB2/neu/HER2 and its role in cancer. Biochim Biophys Acta 1198, 165-184.
2. Salomon, D.S., Brandt, R., Ciardiello, F., and Normanno, N. (1995). Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19, 183-232.
3. Fischbach, G.D., and Rosen, K.M. (1997). ARIA: A neuromuscular junction neuregulin. Annu Rev Neurosci 20, 429-458.
4. Carraway, K.L. III (1996). Involvement of the neuregulins and their receptors in cardiac and neural development. Bioessays 18, 263-266.
5. Meyer, D., and Birchmeier, C. (1995). Multiple essential functions of neuregulin in development. Nature 378, 386-390.
6. Gassmann, M., Casagranda, F., Orioll, D., Simon, H., Lai, C., Klein, R., and Lemke, G. (1995). Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378, 390-394.
7. Lee, K.-F., Simon, H., Chen, H., Bates, B., Hung, M.-C., and Hauser, C. (1995). Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378, 394-398.
8. Kramer, R., Bucay, N., Kane, D.J., Martin, L.E., Tarpley, J.E., and Theill, L.E. (1996). Neuregulins with an lg-like domain are essential for mouse myocardial and neuronal development. Proc Natl Acad Sci USA 93, 4833-4838.
9. Marchionni, M.A., Goodearl, A.D.J., Chen, M.S., Berminghan-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., Wroblewski, D., Lynch, C., Baldassare, M., Hiles, I., Davis, J.B., Hsuan, J.J., Totty, N.F., Otsu, M., McBurney, R.N., Waterfield, M.D., Stroobant, P., and Gwynne, D. (1993). Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362, 312-318.
10. Chang, H., Riese, D.J. II, Gilbert, W., Stern, D.F., and McMahan, U.J. (1997). Ligands for ErbB family receptors encoded by a newly-characterized neuregulin-like gene. Nature 387, 509-512.
11. Carraway, K.L. III, Weber, J.L., Under, M.J., Ledesman, J., Yu, N., Gassmann, M., and Lai, C. (1997). Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 387, 512-516.
12. Ciccodicola, A., Dono, R., Obici, S., Simeone, A., Zollo, M., and Persico, M.G. (1989). Molecular characterization of a gene of the "EGF family" expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 8, 1987-1991.
13. Brandt, R., Normanno, N., Gullick, W.J., Lin, J.H., Harkins, R., Schneider, D., Jones, B.W., Ciardiello, F., Persico, M.G., Armenante, F., Kim, N., and Salomon, D.S. (1994). Identification and biological characterization of an epidermal growth factor-related protein: Cripto-1. J Biol Chem 269, 17320-17328.
14. Shen, M.M., Wang, H., and Leder, P. (1997). A differential display strategy identifies cryptic, a novel EGF-related gene expressed in the axial and lateral mesoderm during mouse gastrulation. Development 124, 429-442.
15. Kannan, S., DeSantis, M., Lohmeyer, M., Riese, D.J. II, Smith, G.H., Hynes, N., Seno, M., Brandt, R., Bianco, C., Persico, G., Kenney, N., Normanno, N., Martinez-Lacaci, I., Ciardiello, F., Stern, D.F., Gullick, W.J., and Salomon, D.S. (1997). Cripto enhances the tyrosine phosphorylation of She and activates MAP-Kinase in mammary epithelial cells. J Biol Chem 272, 3330-3335.
16. Ullrich, A., Coussens, L., Hayflick, J.S., Dull, T.J., Gray, A., Tam, A.W., Lee, J., Yarden, Y., Liebermann, T.A., Schlessinger, J., Downward, J., Mayes, E.L.V., Whittle, N., Waterfield, M.D., and Seeburg, P.H. (1984). Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309, 418-425.
17. Schlechter, A.L., Hung, M.C., Vaidyanathan, L., Weinberg, R.A., Yang-Feng, T.L, Francke, U., Ullrich, A., and Coussens, L. (1985). The neu gene: An erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229, 976-978.
18. Semba, K., Kamata, N., Toyoshima, K., and Yamamoto, T. (1985). A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary adenocarcinoma. Proc Natl Acad Sci USA 82, 6497-6501.
19. Kraus, M.H., Issing, W., Miki, T., Popescu, N.C., and Aarsonson, S.A. (1989). Isolation and characterization of ErbB3, a third member of the ErbB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86, 9193-9197.
20. Plowman, G.D., Whitney, G.S., Neubauer, M.G., Green, J.M., McDonald, V.L., Todaro, G.J., and Shoyab, M. (1990). Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 87, 4905-4909.
21. Plowman, G.D., Culouscou, J.-M., Whitney, G.S., Green, J.M., Carlton, G.W., Foy, L., Neubauer, M.G., and Shoyab, M. (1993). Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90, 1746-1750.
22. Stern, D.F., Heffernan, P.A., and Weinberg, R.A. (1986). p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol Cell Biol 6, 1729-1740.
23. neu: A potential model for receptor interactions. EMBO J 7, 995-1001.
24. King, C.R., Borrello, I., Bellot, F., Comoglio, P., and Schlessinger, J. (1988). EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J 7, 1647-1651.
25. Connelly, P.A., and Stern, D.F. (1990). The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine kinase cascade. Proc Natl Acad Sci USA 87, 6054-6057.
26. Goldman, R., Ben Levy, R., Peles, E., and Yarden, Y. (1990). Heterodimerization of the ErbB1 and ErbB2 receptors in human breast carcinoma cells: A mechanism for receptor transregulation. Biochemistry 29, 11024-11028.
27. Wada, T., Qian, X., and Greene, M.I. (1990). Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell 61, 1339-1347.
28. Muthuswamy, S.K., and Muller, W.J. (1995). Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor. Oncogene 11, 271-279.
29. Riese, D.J. II, Bermingham, Y., van Raaij, T.M., Buckley, S., Plowman, G.D., and Stern, D.F. (1996). Betacellulin activates the epidermal growth factor receptor and ErbB4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-β. Oncogene 12, 345-353.
30. Pinkas-Kramarski, R., Shelly, M., Glathe, S., Ratzkin, B., and Yarden, Y. (1996). Neu differentiation factor/Neuregulin isoforms activate distinct receptor combinations. J Biol Chem 271, 19029-19032.
31. Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B.J., Sela, M., and Yarden, Y. (1996). Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J 15, 2452-2467.
32. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B.J., and Yarden, Y. (1996). A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol 16, 5276-5287.
33. Graus-Porta, D., Beerli, R.R., Daly, J.M., and Hynes, N.E. (1997). ErbB2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling. EMBO J 16, 1647-1655.
34. Karunagaran, D., Tzahar, E., Liu, N., Wen, D., and Yarden, Y. (1995). Neu differentiation factor inhibits EGF binding. J Biol Chem 270, 9982-9990.
35. Sliwkowski, M.X., Schaefer, G., Akita, R.W., Lofgren, J.A., Fitzpatrick, V.D., Nuijens, A., Fendly, B.M., Cerione, R.A., Vandien, R.L., and Carraway, K.L. III. (1994). Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269, 14661-14665.
36. Karunagaran, D., Tzahar, E., Beerli, R., Chen, X., Graus-Porta, D., Ratzkin, B.J., Seger, R., Hynes, N.E., and Yarden, Y. (1996). ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer. EMBO J 15, 254-264.
37. Sherill, J.M., and Kyte, J. (1996). Activation of epidermal growth factor receptor by epidermal growth factor. Biochemistry 35, 5705-5718.
38. Lemmon, M.A., Bu, Z., Ladbury, U.E., Zhou, M., Pinchasi, D., Lax, I., Engelman, D.M., and Schlessinger, J. (1997). Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J 16, 281-294.
39. Barbacci, E.G., Guarino, B.C., Stroh, J.G., Singleton, D.H., Rosnack, K.J., Moyer, J.D., and Andrews, G.C. (1995). The structural basis for the specificity of epidermal growth factor and heregulin binding. J Biol Chem 270, 9585-9589.
40. Gamett, D.C., Pearson, G., Cerione, R.A., and Friedberg, I. (1997). Secondary dimerization between members of the epidermal growth factor receptor family. J Biol Chem 272, 12052-12056.
41. erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci USA 91, 8132-8136.
42. Carraway, K.L. III, Sliwkowski, M.X., Akita, R., Platko, J.V., Guy, P.M., Nuijens, A., Diamonti, A.J., Vandlen, R.L., Cantley, L.C., and Cerione, H.A. (1994). The erbB3 gene product is a receptor for heregulin. J Biol Chem 269, 14303-14306.
43. Riese, D.J. II, van Raaij, T.M., Plowman, G.D, Andrews, G.C., and Stern, D.F. (1995). The cellular response to neuregulins is governed by complex interactions of the ErbB receptor family. Mol Cell Biol 15, 5770-5776.
44. HER2 causes transformation and tumorigenesis of NIH3T3 cells. Proc Natl Acad Sci USA 84, 7159-7163.
45. DiFiore, P.P., Pierce, J.H., Kraus, M.H., Segatto, O., King, C.R., and Aaronson, S.A. (1987b). ErbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237, 179-182.
46. DiFiore, P.P., Segatto, O., Lonardo, F., Fazioli, F., Pierce, J.H., and Aaronson, S.A. (1990). The carboxyl-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. Mol Cell Biol 10, 2749-2756.
47. erbB2 determine the specificity of signal transduction. Mol Cell Biol 11, 3191-3202.
48. Alimandi, M., Romano, A., Curia, M.C., Muraro, R., Fedi, P., Aaronson, S.A., DiFiore, P.P., and Kraus, M.H. (1995). Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10, 1813-1821.
49. Zhang, K., Sun, J., Liu, N., Wen, D., Chang, D., Thomason, A., and Yoshinaga, S.K. (1996). Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J Biol Chem 271, 3884-3890.
50. Cohen, B.D., Green, J.M., Foy, L., and Fell, H.P. (1996). HER4-mediated biological and biochemical properties in NIH3T3 cells. J Biol Chem 271, 4813-4818.
51. Cohen, B.D., Kiener, P.A., Green, J.M., Foy, L., Fell, H.P., and Zhang, K. (1996). The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J Biol Chem 271, 30897-30903.
52. Fazioli, F., Kim, U.-H., Rhee, S.G., Molloy, C.J., Segatto, O., and DiFiore, P.P. (1991). The erbB2 mitogenic signaling pathway: Tyrosine phosphorylation of phospholipase C-γ and GTPase activating protein does not correlate with erbB2 mitogenic potency. Mol Cell Biol 11, 2040-2048.
53. Kokai, Y., Myers, J.N., Wada, T., Brown, V.I., LeVea, C.M., Davis, J.G., Dobashi, K., and Greene, M.I. (1989). Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58, 287-292.
54. Carter, T.H., and Kung, H.J. (1994). Tissue specific transformation by oncogenic mutants of epidermal growth factor receptor. Crit Rev Oncog 5, 389-428.
55. van der Geer, P., Hunter, T., and Lindberg, R.A. (1994). Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 10, 521-337.
56. Kumar, V., Bustin, S.A., and McKay, I.A. (1995). Transforming growth lactor alpha. Cell Biol Int 19, 373-388.
57. Hunter, T. (1995). Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 80, 225-236.
58. Earp, H.S., Dawson, T.L., Li, X., and Yu, H. (1995) Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 35, 115-132.
59. Bacus, S.S., Yarden, Y., Oren, M., Chin, D.M., Lyass, L., Zelnick, C.R., Kazarov, A., Toyofuku, W., Gray-Bablin, J., Beerli, R., Hynes, N.E., Nikiforov, M., Haffner, R., Gudkov, A., and Keyomarsi, K. (1996). Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells. Oncogene 12, 2535-2547.
60. Levkowitz, G., Klapper, L.N., Tzahar, E., Freywald, A., Sela, M., and Yarden, Y. (1996). Coupling of the c-Cbl protooncogene product to ErbB1/EGF receptor but not to other ErbB proteins Oncogene 12, 1117-1125.
61. Zrihan-Licht, S., Lim, J., Keydar, I., Sliwkowski, M.X., Groopman, J.E., and Avraham, H. (1997). Association of Csk-homologous Kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells. J Biol Chem 272, 1856-1863.
62. Marchionni, M.A. (1995). Neu tack on neuregulin. Nature 378, 334-335.
63. Lemke, G. (1996). Neuregulins in development. Mol Cell Neurosci 7, 247-262.
64. Cook, P.W., Ashton, N.M., Karkaria, C.E., Siess, D.C., and Shipley, G.D. (1995). Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity. J Cell Physiol 163, 418-429.
65. Shum, L., Reeves, S.A., Kuo, A.C., Fromer, E.S., and Derynck R. (1994). Association of the transmembrane TGF-alpha precursor with a protein kinase complex. J Cell Biol 125, 903-916.
66. Shum, L., Turck, C.W., and Derynck, R. (1996). Cysteines 153 and 154 of transmembrane transforming growth factor-alpha are palmitoylated and mediate cytoplasmic protein association. J Biol Chem 271, 28502-28508.
67. Weiss, F.U., Daub, H., and Ullrich, A. (1997). Novel mechanisms of RTK signal generation. Curr Opin Genet Dev 7, 80-86.
68. Sachsenmaier, C., Radler-Pohl, A., Zinck, R., Nordheim, A., Herrlich, P., and Rahmsdorf, H.J. (1994). Involvement of growth factor receptors in the mammalian UVC response. Cell 78, 963-972.
69. Rao, G.N. (1996). Hydrogen peroxide induces complex formation of Shc-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. Oncogene 13, 713-719.
70. Bae, Y.S., Kang, S.W., Seo, M.S., Baines, I.C., Tekle, E., Chock, P.B., and Rhee, S.G. (1997). Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. J Biol Chem 272, 217-221.
71. Daub, H., Weiss, F.U., Wallasch, C., and Ullrich, A. (1996). Role of transactivation of the EGF receptor in signalling by G-protem-coupled receptors. Nature 379, 557-560.
72. Sα mediates epidermal growth factor-elicited stimulation of rat cardiac adenylate cyclase. J Biol Chem 265, 21317-23122.
73. Sα by the epidermal growth factor receptor involves phosphorylation. J Biol Chem 271, 6947-6951.
74. Shoyab, M., Plowman, G.D., McDonald, V.L., Bradley, J.G., and Todaro, G.J. (1989). Structure and function of human amphiregulin: A member of the epidermal growth factor family. Science 243, 1074-1076.
75. Higashiyama, S., Abraham, J.A., Miller, J., Fiddes, J.C., and Klagsbrun, M. (1991). A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251, 936-939.
76. erbB2. J Biol Chem 268, 2924-2931.
77. erbB4. Nature 366, 473-475.
78. Shing, Y., Christofori, G., Hanahan, D., Ono, Y., Sasada, R., Igarashi, K., and Folkman, J. (1993). Betacellulin: A mitogen from pancreatic β cell tumors. Science 259, 1604-1607.
79. Toyoda, H., Komurasaki, T., Uchida, D., Takayama, Y., Isobe, T., Okuyama, T., and Hanada, K. (1995). Epiregulin: A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 270, 7495-7500.
80. Riese, D.J. II, Kim, E.D., Elenius, K., Buckley, S., Klagsbrun, M., Plowman, G.D., and Stern, D.F. (1996). The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB3, and ErbB4. J Biol Chem 271, 20047-20052.
81. Beerli, R.R., and Hynes, N.B. (1996). Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem 271, 6071-6076.
82. Elenius, K., Paul, S., Allison, G., Sun, J., and Klagsbrun, M. (1997). Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 16, 1268-1278.
83. Riese, D.J. II, Komurasaki, T., Plowman, G.D., and Stern, D.F. Activation of ErbB4 by the bifunctional EGF family hormone epiregulin is regulated by ErbB2. (submitted).